468 related articles for article (PubMed ID: 23799715)
21. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine in adults aged 65 years and older - Advisory Committee on Immunization Practices (ACIP), 2012.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Jun; 61(25):468-70. PubMed ID: 22739778
[TBL] [Abstract][Full Text] [Related]
22. Tetanus-diphtheria-acellular pertussis vaccination of adults in the USA.
Gidengil CA; Sandora TJ; Lee GM
Expert Rev Vaccines; 2008 Jul; 7(5):621-34. PubMed ID: 18564017
[TBL] [Abstract][Full Text] [Related]
23. Persistence of antibodies 3 years after booster vaccination of adults with combined acellular pertussis, diphtheria and tetanus toxoids vaccine.
Weston W; Messier M; Friedland LR; Wu X; Howe B
Vaccine; 2011 Nov; 29(47):8483-6. PubMed ID: 21945698
[TBL] [Abstract][Full Text] [Related]
24. Surveillance of Vaccination Coverage Among Adult Populations - United States, 2014.
Williams WW; Lu PJ; O'Halloran A; Kim DK; Grohskopf LA; Pilishvili T; Skoff TH; Nelson NP; Harpaz R; Markowitz LE; Rodriguez-Lainz A; Bridges CB;
MMWR Surveill Summ; 2016 Feb; 65(1):1-36. PubMed ID: 26844596
[TBL] [Abstract][Full Text] [Related]
25. Tdap vaccine: current indications for adolescent and adult patients in the United States.
Kirchner JT
J Am Osteopath Assoc; 2011 Oct; 111(10 Suppl 6):S7-9. PubMed ID: 22086895
[TBL] [Abstract][Full Text] [Related]
26. Waning Tdap Effectiveness in Adolescents.
Klein NP; Bartlett J; Fireman B; Baxter R
Pediatrics; 2016 Mar; 137(3):e20153326. PubMed ID: 26908667
[TBL] [Abstract][Full Text] [Related]
27. Factors Related to Pertussis and Tetanus Vaccination Status Among Foreign-Born Adults Living in the United States.
Sánchez-González L; Rodriguez-Lainz A; O'Halloran A; Rowhani-Rahbar A; Liang JL; Lu PJ; Houck PM; Verguet S; Williams WW
J Community Health; 2017 Jun; 42(3):573-582. PubMed ID: 27837358
[TBL] [Abstract][Full Text] [Related]
28. Tetanus, diphtheria and acellular pertussis (Tdap) vaccination among healthcare personnel-United States, 2011.
Lu PJ; Graitcer SB; O'Halloran A; Liang JL
Vaccine; 2014 Jan; 32(5):572-8. PubMed ID: 24308960
[TBL] [Abstract][Full Text] [Related]
29. Receipt of tetanus-containing vaccinations among adolescents aged 13 to 17 years in the United States: National Immunization Survey-Teen 2007.
Jain N; Stokley S; Cohn A
Clin Ther; 2010 Aug; 32(8):1468-78. PubMed ID: 20728760
[TBL] [Abstract][Full Text] [Related]
30. Cocooning infants: Tdap immunization for new parents in the pediatric office.
Walter EB; Allred N; Rowe-West B; Chmielewski K; Kretsinger K; Dolor RJ
Acad Pediatr; 2009; 9(5):344-7. PubMed ID: 19596219
[TBL] [Abstract][Full Text] [Related]
31. Knowledge and Acceptability about Adult Pertussis Immunization in Korean Women of Childbearing Age.
Ko HS; Jo YS; Kim YH; Park YG; Wie JH; Cheon J; Moon HB; Lee Y; Shin JC
Yonsei Med J; 2015 Jul; 56(4):1071-8. PubMed ID: 26069132
[TBL] [Abstract][Full Text] [Related]
32. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Jan; 60(1):13-5. PubMed ID: 21228763
[TBL] [Abstract][Full Text] [Related]
33. Additional recommendations for use of tetanus toxoid, reduced-content diphtheria toxoid, and acellular pertussis vaccine (Tdap).
;
Pediatrics; 2011 Oct; 128(4):809-12. PubMed ID: 21949151
[TBL] [Abstract][Full Text] [Related]
34. National and State-Specific Td and Tdap Vaccination of Adult Populations.
Lu PJ; O'Halloran A; Ding H; Liang JL; Williams WW
Am J Prev Med; 2016 May; 50(5):616-626. PubMed ID: 26614276
[TBL] [Abstract][Full Text] [Related]
35. Safety of reduced-antigen-content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine.
Zepp F; Knuf M; Habermehl P; Mannhardt-Laakmann W; Howe B; Friedland LR
J Pediatr; 2006 Nov; 149(5):603-610. PubMed ID: 17095328
[TBL] [Abstract][Full Text] [Related]
36. Universal tetanus, diphtheria, acellular pertussis (Tdap) vaccination of adults: What Canadian health care providers know and need to know.
MacDougall D; Halperin BA; MacKinnon-Cameron D; Li L; McNeil SA; Langley JM; Halperin SA
Hum Vaccin Immunother; 2015; 11(9):2167-79. PubMed ID: 26090861
[TBL] [Abstract][Full Text] [Related]
37. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.
Grimprel E; von Sonnenburg F; Sänger R; Abitbol V; Wolter JM; Schuerman LM
Vaccine; 2005 May; 23(28):3657-67. PubMed ID: 15882526
[TBL] [Abstract][Full Text] [Related]
38. Shortened interval between tetanus vaccines.
Lodolce AE
Ann Pharmacother; 2012 Jun; 46(6):884-8. PubMed ID: 22669800
[TBL] [Abstract][Full Text] [Related]
39. Pertussis in adolescents and adults: should we vaccinate?
Lee GM; Lebaron C; Murphy TV; Lett S; Schauer S; Lieu TA
Pediatrics; 2005 Jun; 115(6):1675-84. PubMed ID: 15930232
[TBL] [Abstract][Full Text] [Related]
40. U.S. Postlicensure safety surveillance for adolescent and adult tetanus, diphtheria and acellular pertussis vaccines: 2005-2007.
Chang S; O'Connor PM; Slade BA; Woo EJ
Vaccine; 2013 Feb; 31(10):1447-52. PubMed ID: 23142308
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
